Experience of using a radioprotector in X-ray therapy of patients with syringomyelia

Cover Page

Cite item

Full Text

Abstract

During X-ray therapy of 86 patients with a developed form of syringomyelia, the simultaneous administration of cystamine hydrobromide as a protector prevented the development of complications from radiation therapy. In parallel, the clinical course of the disease improved.

About the authors

H. S. Khamitov

Kazan Medical Institute; Moscow Institute of Physics and Technology

Author for correspondence.
Email: info@eco-vector.com
Russian Federation

M. N. Volkov

Kazan Medical Institute; Moscow Institute of Physics and Technology

Email: info@eco-vector.com
Russian Federation

V. M. Sirotkin

Kazan Medical Institute; Moscow Institute of Physics and Technology

Email: info@eco-vector.com
Russian Federation

V. F. Bogoyavlensky

Kazan Medical Institute; Moscow Institute of Physics and Technology

Email: info@eco-vector.com
Russian Federation

O. V. Mikhailova

Kazan Medical Institute; Moscow Institute of Physics and Technology

Email: info@eco-vector.com
Russian Federation

R. Sh. Atnagulova

Kazan Medical Institute; Moscow Institute of Physics and Technology

Email: info@eco-vector.com
Russian Federation

V. I. Tretyakov

Kazan Medical Institute; Moscow Institute of Physics and Technology

Email: info@eco-vector.com
Russian Federation

L. G. Popova

Kazan Medical Institute; Moscow Institute of Physics and Technology

Email: info@eco-vector.com
Russian Federation

T. I. Ruban

Kazan Medical Institute; Moscow Institute of Physics and Technology

Email: info@eco-vector.com
Russian Federation

I. A. Andrushko

Kazan Medical Institute; Moscow Institute of Physics and Technology

Email: info@eco-vector.com
Russian Federation

L. V. Nikonova

Kazan Medical Institute; Moscow Institute of Physics and Technology

Email: info@eco-vector.com
Russian Federation

References


© 1981 Eco-Vector





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies